SWOG clinical trial number
SWOG-8789

A Randomized Study of Etoposide + Cisplatin and Etoposide + Carboplatin (CBDCA) in the Managements of Good Risk Patients with Advanced Germ Cell Tumors

Closed
Phase
Published
Abbreviated Title
A Randomized Study of Etoposide + Cisplatin and Etoposide + Carboplatin (CBDCA) in the Managements of Good Risk Patients with Advanced Germ Cell Tumors
Activated
08/15/1988
Closed
12/15/1990

Publication Information Expand/Collapse

1993

A randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good risk germ cell tumors: A multi-institutional study.

DF Bajorin;MF Sarosdy;DG Pfister;M Mazumdar;RJ Motzer;HI Scher;NL Geller;WR Fair;H Herr;P Sogani;J Sheinfeld;P Russo;V Vlamis;R Carey;NJ Vogelzang;ED Crawford;GJ Bosi JCO 11(4):598-606

1991

A randomized trial of etoposide + carboplatin (EC) vs. etoposide + cisplatin (EP) in patients (PTS) with metastatic germ cell tumors (GCT).

DF Bajorin;MF Sarosdy;GJ Bosi;S Welsen;G Heller ASCO 10:168:(535)